Magnex 1g Injection is a sterile, injectable antibiotic formulation containing Cefoperazone 500 mg and Sulbactam 500 mg. Cefoperazone is a third-generation cephalosporin antibiotic with broad-spectrum bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens, including beta-lactamase-producing strains. Sulbactam is a potent beta-lactamase inhibitor that enhances the efficacy of Cefoperazone by preventing enzymatic degradation, thereby extending its antibacterial spectrum. Magnex 1g Injection is indicated for the treatment of moderate to severe infections such as respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and gynecological infections caused by susceptible organisms. The combination is particularly useful in combating resistant bacterial strains where beta-lactamase production compromises antibiotic effectiveness. Administration is typically via intravenous or intramuscular injection, with dosage and duration determined based on the severity of infection, pathogen susceptibility, and patient-specific factors. Caution is advised in patients with hypersensitivity to cephalosporins or penicillins, and renal or hepatic impairment. Common adverse effects include gastrointestinal disturbances, hypersensitivity reactions, and transient hematological changes. Magnex 1g Injection should be used under strict medical supervision with appropriate microbiological monitoring to ensure optimal therapeutic outcomes.